12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jan F Tack, Professor
Department of Gastroenterology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
Study Chair - Lin Chang, Professor
Digestive Health and Nutrition Clinic. University of California, Los Angeles, CA, USA
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
127 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Haskovo, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Rousse, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Veliko Tarnovo, Bulgaria
- Facility name not stated
Karlovy Vary, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Ústí nad Labem, Czechia
- Facility name not stated
Ústí nad Orlicí, Czechia
- Facility name not stated
Bobigny, Île-de-France Region, France
- Facility name not stated
Bordeaux, France
- Facility name not stated
Nantes, France
- Facility name not stated
Nice, France
- Facility name not stated
Rouen, France
- Facility name not stated
Stuttgart, Baden-Wurttemberg, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Essen, Germany
- Facility name not stated
Hamburg, Germany
- Facility name not stated
Hamburg, Germany
- Facility name not stated
Bari, Italy
- Facility name not stated
Bari, Italy
- Facility name not stated
Bologna, Italy
- Facility name not stated
Florence, Italy
- Facility name not stated
Pavia, Italy
- Facility name not stated
Rome, Italy
- Facility name not stated
Bydgoszcz, Poland
- Facility name not stated
Częstochowa, Poland
- Facility name not stated
Krakow, Poland
- Facility name not stated
Lublin, Poland
- Facility name not stated
Wroclaw, Poland
- Facility name not stated
Târgu Mureş, Jud. Mures, Romania
- Facility name not stated
Târgu Mureş, Mureș County, Romania
- Facility name not stated
Timișoara, Timiș County, Romania
- Facility name not stated
Timișoara, Timiș County, Romania
- Facility name not stated
Brasov, Romania
- Facility name not stated
Brasov, Romania
- Facility name not stated
Bucharest, Romania
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2014
- Primary completion
- 30 Jun 2015
- Completion
- 30 Jun 2015
- Last update posted
- 19 Jan 2017
- Registered enrollment
- 535
- Registry id
- NCT02107196
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.